Skip to content

Clinical trials

Prostatic Hyperplasia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: United Kingdom Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20073
20081
20091
20103
20111
20121
20142
20151
20161
20171
20182
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting2
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
NeoTract, Inc.3
Astellas Pharma Europe B.V.2
PROCEPT BioRobotics2
AEterna Zentaris1
Aberdeen Royal Infirmary1
Allergan1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia26
Lower Urinary Tract Symptoms9
Prostatic Neoplasms2
Hypertrophy1
Neoplasms1
Sexual Dysfunction, Physiological1
Urinary Bladder, Overactive1
Urinary Incontinence1
Urinary Retention1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.